[11C]AZ12807110
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for [11C]AZ12807110, covering 2015-01-28 to 2015-01-28. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of Histamine H3 Receptor Radioligand [11C]AZ12807110 and Histamine H3 Receptor Occupancy of AZD5213 After Oral Administration [Phase 1]